Semaphorin 3F and Neuropilin-2 Control the Migration of Human T-Cell Precursors
Daniella Arêas Mendes‐da‐Cruz(Fundação Oswaldo Cruz), Olivier Hermine(Centre National de la Recherche Scientifique), Salete Smaniotto(Universidade Federal de Alagoas), Danielle Canioni(Inserm), Pierre Milpied(Délégation Paris 5), Nawel Bedjaoui(Inserm), Norbert Ifrah(Institut National du Cancer), Philippe Bousso(Inserm), Yves Lepelletier(Délégation Paris 5), Stéphane Leprêtre(Normandie Université), Vahid Asnafi(Hôpital Necker-Enfants Malades), Mireille Dardenne(Hôpital Necker-Enfants Malades), Frédéric Baleydier(University of Geneva), Karl Balabanian(Inserm), Anne Brignier(Délégation Paris 5), Wilson Savino(Fundação Oswaldo Cruz), Elizabeth Macintyre(Inserm), Hervé Dombret(University of London Institute in Paris), Yves Bertrand(Hôpital Debrousse), Amédée Renand(Inserm)
Cited by 51
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k